NYU Langone Health Perlmutter Cancer Center Clinical Whole-Genome DNA Methylation Profiling for Brain Tumors
Oct 25, 2019
NYU Langone Health's Perlmutter Cancer Center has launched clinical whole-genome DNA methylation profiling for patients with brain tumors. This molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to identify and subtype brain tumors.
The test received New York State Department of Health approval on April 3.